Amex Exploration Reviews 2020 Achievements
MONTREAL, QC / ACCESSWIRE / January 5, 2021 / Amex Exploration Inc. (“Amex or the…
Year: 2021
Roscan Gold Receives Additional $2 Million from Warrants Exercised and Increases to Six (6) Drills at its Kandiole Project
TORONTO, ON / ACCESSWIRE / January 5, 2021 / Roscan Gold Corporation (“Roscan” or the “Company”)…
How This Empowered Entrepreneur, International Speaker, Author & Philanthropist Built a 6-Figure Business Amidst the Pandemic
LOS ANGELES, CA / ACCESSWIRE / January 5, 2021 / You probably read a lot…
Good Neighbors & Kia Motors Conducts GLP Project in Mai Chau, Vietnam
“Establishing a sustainable recycling system… Improving the local community environment and helping residents to become…
Hemogenyx Pharmaceuticals PLC Announces CAR-T Master Translational Agreement with University of Pennsylvania
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
CB Radio Use In The US Sees A Significant Uptick And Revived Interest During The COVID-19 Pandemic
The COVID-19 Pandemic has interestingly led to an uptick in the use and interest in…
Hilltop Credit Partners completes £15million loan for high-end residential development in Taplow, Buckinghamshire
Funds advised by Hilltop Credit Partners Limited (“Hilltop”) have provided a development finance facility of…
Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine
PRESS RELEASE Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a…
Polyphor to Take Part in Panel Discussion on Novel Oncology Targets at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
ALLSCHWIL, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) announced today that…
Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
ViGeneron signs global collaboration agreement for ophthalmic gene therapy development
Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye…
Innate’s First NK Cell Engager Selected by Sanofi as Drug Candidate for Development
IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE) that uses Innate’s proprietary multispecific antibody format…
Nicox Highlights Successful 2020 Development Progress and Clinical Milestones for 2021
Press Release Nicox Highlights Successful 2020 Development Progress and Clinical Milestones for 2021 Initiated…
Bavarian Nordic to Supply Smallpox Vaccines to Three European Countries
COPENHAGEN, Denmark, January 5, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
AB2 Bio to Participate in Orphan Disease Panel Discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
Investors can pre-register for the event here LAUSANNE, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) —…
Roche’s novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designation in combination with Tecentriq for PD-L1-high non-small cell lung cancer
Tiragolumab is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation (BTD) and marks…
Innate’s first NK cell engager selected by Sanofi as drug candidate for development
Marseille, Jan. 05, 2021 (GLOBE NEWSWIRE) — IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE)…
Franciosi Consulting Reviewing the Science and History of Psychedelic Drug Use for Treating Depression, Anxiety and Addiction
VANCOUVER, British Columbia, Jan. 04, 2021 (GLOBE NEWSWIRE) — Lui Franciosi of Franciosi Consulting Ltd….
Verizon makes high-speed, reliable internet more accessible with Fios Forward
Qualifying customers can get fast internet on the residential internet service rated #1 in customer…
Pennexx Has Completed All Necessary Approvals and Agreements to Release its Mastercard™ Your Social Offers Prepaid Debit Card
Philadelphia, PA, Jan. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Pennexx (PNNX) received the final signed document…